NTLA Sale Disclosure
Leonard John M · SEC Form 4 · Filed Nov 3, 2026
Sale
Calculated transaction value
$107.91K
Leonard John M President And CEO
NTLA
Transaction date
Nov 2, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 1 day later
NTLA daily price context
Close on/before transaction
$11.66
Nov 2, 2026
First close after public filing
$12.31
Nov 4, 2026
Return after filing · so far
-7.8%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 9,000 shares @ $11.99
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-445417
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$107.91K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Intellia Therapeutics, Inc. NTLA Current | Sale | Nov 2, 2026 | $107.91K |